Efficacy and Toxicity of Alternative Radiation Treatment Schemes for Patients With Hematologic Malignancies: A Collaborative ILROG COVID Era Report

PURPOSE/OBJECTIVE(S): The COVID19 pandemic required radiation oncologists (ROs) to consider shorter treatment courses to minimize patient and staff exposure and conserve healthcare resources. Hematologic ROs adopted hypofractionated radiation therapy (hRT) regimens according to guidelines published...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunther, J.R., Yang, J.C., Hajj, C., Ng, A.K., Brady, J.L., Cheng, S., Levis, M., Qi, S., Mikhaeel, G., Ricardi, U., Illidge, T., Turin, A., Knafl, M., Specht, L., Dabaja, B., Yahalom, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
2625
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536223/
http://dx.doi.org/10.1016/j.ijrobp.2021.07.961

Ejemplares similares

Ejemplares similares